FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to novel indolizine derivatives of formula 
, to their pharmaceutically acceptable salts or prodrugs, which represent C1-6alkyl ethers, where values U, R1, R2, R3 are given in item one of the formula.
EFFECT: compounds possess an inhibiting activity with respect to xanthine oxidase, which makes it possible to use them in a pharmaceutical composition for the prevention or treatment of a disease, selected from the group, consisting of hyperurecemia, gout nodule, gout arthritis with hyperurecemia of the renal disorder and urine concrements.
18 cl, 17 tbl, 76 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INDOLE DERIVATIVE AND ITS USE IN THERAPEUTIC PURPOSES | 2008 |
|
RU2477274C2 |
| DERIVATIVE, CONTAINING CONDENSED RING STRUCTURE, AND ITS APPLICATION IN MEDICINE | 2009 |
|
RU2512547C2 |
| 5-MEMBERED HETEROCYCLIC COMPOUND AND ITS APPLICATION FOR MEDICINAL PURPOSES | 2008 |
|
RU2515968C2 |
| 3-ALKYLIDENHYDRAZINO-HETEROARYL COMPOUNDS AS ACTIVATORS OF THROMBOPROTEIN RECEPTOR | 2004 |
|
RU2358970C2 |
| DERIVATIVES OF ISOXAZOLE, THEIR USE IN PRODUCTION OF AGENT INHIBITING MONOAMINE OXIDASE ACTIVITY, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF ACTIVITY OF MONOAMINE OXIDASE TYPE B | 1995 |
|
RU2140414C1 |
| ARYLSULPHONAMIDE CCR3 ANTAGONISTS | 2010 |
|
RU2539591C2 |
| NEW PHENOL DERIVATIVE | 2010 |
|
RU2536689C2 |
| NITROGEN CONTAINING HETEROCYCLIC DERIVATIVE SHOWING TYPE I 11β -HYDROXYSTEROIDDEHYDROGENASE INHIBITORY ACTIVITY | 2008 |
|
RU2455285C2 |
| 2,5-DISUBSTITUTED ARYLSULPHONAMIDE CCR3 ANTAGONISTS | 2010 |
|
RU2532515C2 |
| QUINOLINE COMPOUNDS, METHODS FOR PRODUCTION THEREOF AND USE THEREOF AS MEDICINAL AGENT WHICH INHIBITS URATE TRANSPORTER | 2016 |
|
RU2715229C2 |
